1.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 55 and over
Sponsor: Other
Protocol IDs: 191199-HMO-CTIL, NCT00162513
|
|
2.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BCM-H-19747, H 19747, BCM-PRIMAL, NCT00602121
|
|
3.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 75
Sponsor: NCI
Protocol IDs: NCI-08-C-0051, 08-C-0051, NCI-P06049, NCT00608166
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HaemaCBFWT102, Carreras 04/25f, NCT00153582
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: JHOC-J05121, J05121, NCT00363649
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GIMEMA-CML0206, EUDRACT-2006-006189-40, EU-20724, CML0206, NCT00466726
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: NHLBI
Protocol IDs: NHLBI-07-H-0159, 07-H-0159, NCT00499772
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GRNVAC1 CP06-151, NCT00510133
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: NHLBI
Protocol IDs: 070091, 07-H-0091, NCT00433745
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UCSD-080497, CLL-35-202, NCT00849524
|
|
11.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H11967, CLIPA, NCT00078520
|
|
12.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 17656, CLONTAK, NCT00224354
|
|
13.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 06-196, NCT00442130
|
|
14.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 418-A-2209, NCT00455221
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2007-0095, NCT00473226
|
|
16.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2005-0379, NCT00514189
|
|
17.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BB-IND 13254, NCT00672152
|
|
18.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: O5CC14, EudraCT 2005-000806-29, GTAC GTAC098, NCT00718250
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 08-160, NCT00809250
|
|
20.
|
Phase: Phase I
Type: Treatment
Status: Approved-not yet active
Age: Not specified
Sponsor: Other
Protocol IDs: 2003-0564, NCT00866346
|
|
21.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: NCI
Protocol IDs: JHOC-J06118, J06118, NCT00469820
|
|
22.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-15025, INNO-305 WT-1, USF IRB-105946, NCT00665002
|
